In October 2016, Valenta organized two scientific symposiums within the XXII Joint Russian Gastroenterology Week. The agenda of the event comprised the discussion of a wide range of theoretical and practical issues of modern gastroenterology and endoscopy, and of urgent issues of specialists’ post-graduate training.
The first symposium “Intestinal Microbiota and Its Influence on GIT Functioning”, chaired by V.T. Ivashkin, Academician of RAS, MD, Professor, and A.S. Trukhmanov, MD, Professor, was devoted to discussion of the issues of intestinal microbiome as the key factor of influence on functionality of all human organs and systems, including immune, endocrine and nervous systems. Experts presented the latest achievements of the world medical science in the field of intestinal microbiome, and emphasized the importance of administering probiotics for therapy of diseases of gastrointestinal tract (GIT), taking into account the specificity of the Russian population.
Besides, each participant presented the opinion about the influence of GIT motility on the status of intestinal microbiota in general, on the digestive system, and on development of GIT functional disorders. The majority of experts agreed that the efficacy of therapy of GIT functional disorders (functional dyspepsia and IBS) was increased by application of medicines of general action – regulators of motility both in upper and lower GIT segments. Besides, restoration of intestinal microflora helps to remedy problems with stool, so experts recommend osmotic laxatives with prebiotic action, which provide curative effect on intestines and improve microflora.
In conclusion, L.I. Butorova, CM, Associate Professor at the Department of Polyclinic Therapy, Medical Faculty, at SEGFI HE Sechenov First MSMU, Ministry of Healthcare of Russia, spoke about flatulence syndrome and pharmatherapeutic methods applied to combat this functional disorder. She also described new methods aimed to prevent the start of the disease or to stop its further development.
Within the second symposium, clinical recommendations of the Russian Gastroenterological Association were presented dealing with treatment of GIT functional diseases, including dyspepsia, gallstones, sphincter of Oddi dysfunction, chronic constipation and abdominal pains.
Gastroenterology is one of the key therapeutic spheres included in Valenta’s list of priorities. The Company actively invests in its current gastroenterology portfolio, as well as in development of new products aimed to combat dyspeptic disorders, irritated bowel syndrome, biliary tract dysfunction, flatulence, etc. One of the main goals of the Company is to provide the effective and affordable aid to patients in therapy of GIT diseases.
All participants highly appreciated the events organized within the XXII Russian Gastroenterology Week and acknowledged them useful from both theoretical and practical points of view. The Gastroenterology Week is one of few platforms giving opportunity to the leading doctors and healthcare specialists to share experience, to present new international and Russian researches and developments in the field of gastroenterology, and to discuss the latest therapeutic techniques.